NCT05642195 2026-06-05Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung CancerNational Institutes of Health Clinical Center (CC)Phase 1/2 Suspended30 enrolled